Related Articles
TREATMENT WITH LUTEINIZING-HORMONE-RELEASING HORMONE ANTAGONIST SB-75 DECREASES LEVELS OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND ITS MESSENGER-RNA IN OV-1063 HUMAN EPITHELIAL OVARIAN-CANCER XENOGRAFTS IN NUDE-MICE
Bombesin and epidermal growth factor potentiate the effect of cytotoxic LH-RH analog AN-152 in vitro
LH-RH receptors in human colorectal cancers: Unexpected molecular targets for experimental therapy
Down-regulation and change in subcellular distribution of receptors for luteinizing hormone-releasing hormone in OV-1063 human epithelial ovarian cancers during therapy with LH-RH antagonist Cetrorelix.
Receptor mediated antiproliferative effects of the cytotoxic LHRH agonist AN-152 in human ovarian and endometrial cancer cell lines.